Neuralink closes Series E funding round

Neuralink has confirmed the closure of its Series E funding round at USD 650 million, with backing from Ark Invest, DFJ Growth, Founders Fund, G42, Human Capital, Lightspeed, QIA, Sequoia Capital, Thrive Capital, Valor Equity Partners, Vy Capital, and others. The funding will expand its clinical trials in the US, Canada, and UAE, and advance brain-computer interface applications for vision and speech restoration.